Jason Joel Schwartz
Physician in Salt Lake City, UT

License number
Utah 5950069-8905
Issued Date
Sep 2, 2005
Expiration Date
Jan 31, 2012
Category
Physician
Type
Physician/Surgeon CS (Schedule 2-5)
Address
Address
Salt Lake City, UT
Education
UNIVERSITY OF ILLINOIS COLLEGE OF MEDICINE

Personal information

See more information about Jason Joel Schwartz at radaris.com
Name
Address
Phone
Jason Schwartz, age 49
477 E Afton Cir, Sandy, UT 84070

Professional information

Jason J Schwartz Photo 1

Dr. Jason J Schwartz - MD (Doctor of Medicine)

Specialties:
General Surgery
Procedures:
Dressing and/or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy), Incisional/Ventral Hernia Repair, Open, Pancreatectomy (incl. Pancreas Transplant & Whipple Procedure), Peripheral Artery Catheterization, Port Placements or Replacements, Renal Transplant and Nephrectomy
Conditions:
Hyperparathyroidism, Incisional Hernia, Intestinal Obstruction, Liver Cancer, Peripheral Vascular Disease (PAD, PVD)
Certifications:
General Surgery, 2004
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
University Hospital
30 N 1900 E, Salt Lake City 84132
University of Utah Health Care
50 North Medical Dr, Salt Lake City 84132
University Hospital
30 N 1900 E, Salt Lake City 84132
University of Utah Health Care
50 North Medical Dr, Salt Lake City 84132
Education:
Medical School
University Of Illinois College Of Medicine Chicago
Graduated: 1996
University Of Tx Sw Med Center
Graduated: 1997
Graduated: 2002
Mayo Clinic
Graduated: 2005
University Of Tx
Graduated: 2001


Jason Schwartz Photo 2

Account Management At Ebay

Position:
Account Management at eBay
Location:
Greater Salt Lake City Area
Industry:
Internet
Work:
eBay - Account Management


Jason Schwartz Photo 3

Use Of Angiogenesis Antagonists In Conditions Of Abnormal Venous Proliferation

US Patent:
2011000, Jan 6, 2011
Filed:
Nov 10, 2008
Appl. No.:
12/741979
Inventors:
Jason Joel Schwartz - Salt lake City UT, US
Thomas P. Kennedy - Charlotte NC, US
International Classification:
A61K 31/27, A61K 31/315, A61P 1/16
US Classification:
514491, 514476
Abstract:
The present application describes therapy with angiogenesis antagonists such as anti-VEGF antibodies. In particular, the application describes the use of such angiogenesis antagonists to treat end-stage liver disease and end-stage liver disease complications. The present application also describes the use of such angiogenesis antagonists to treat disorders of altered venous proliferation such hemorrhoids and varicose veins.